atorvastatin calcium
- Product NDC
- 16714-875
- 11-digit product format
- 167140875
- Labeler code
- 16714
- Product ID
- 16714-875_190288d6-46d8-4956-b2d3-248594ca2036
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- atorvastatin calcium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Northstar Rx LLC.
- Application
- ANDA206536
- Marketing category
- ANDA
- Marketing start
- 2018-12-01
- Marketing end
- 2023-04-30
- Substance
- ATORVASTATIN CALCIUM TRIHYDRATE
- Active strength
- 20 mg/1
- Pharmacologic classes
- HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 16714-875-01 | 16714087501 | 90 TABLET in 1 BOTTLE (16714-875-01) | 90 tablet | 2018-12-01 | 2023-04-30 | No | No | Current |
| 16714-875-02 | 16714087502 | 500 TABLET in 1 BOTTLE (16714-875-02) | 500 tablet | 2018-12-01 | 2023-04-30 | No | No | Current |
| 16714-875-03 | 16714087503 | 1000 TABLET in 1 BOTTLE (16714-875-03) | 1000 tablet | 2018-12-01 | 2023-04-30 | No | No | Current |